Y0001427

Carvedilol

European Pharmacopoeia (EP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 72956-09-3

Synonym(S): 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol, BM-14190

Select a Size

Pack Size SKU Availability Price
50 MG Y0001427-50-MG In Stock ₹ 14,072.50

Y0001427 - 50 MG

₹ 14,072.50

In Stock

Quantity

1

Base Price: ₹ 14,072.50

GST (18%): ₹ 2,533.05

Total Price: ₹ 16,605.55

grade

pharmaceutical primary standard

API family

carvedilol

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

OC(COC1=CC=CC2=C1C3=C(C=CC=C3)N2)CNCCOC4=CC=CC=C4OC

InChI

1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3

InChI key

OGHNVEJMJSYVRP-UHFFFAOYSA-N

Gene Information

human ... ADRA1A(148) , ADRA1B(147) , ADRA1D(146) , ADRB1(153) , ADRB2(154) , ADRB3(155)

Other Options

Image Product Name Manufacturer Price Range
Enzo Life Sciences Carvedilol (100mg). CAS: 72956-09-3
-- ₹ 8,392.70
Selleck Chemical LLC Carvedilol 50mg 72956-09-3 BM-14190, SKF 105517
-- ₹ 15,699.60
Carvedilol Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
-- ₹ 12,905.00
eMolecules​ Carvedilol | 72956-09-3 | 1G | Purity: 98%
-- ₹ 3,424.72
Sigma Aldrich Fine Chemicals Biosciences Carvedilol >=98% (HPLC), solid | 72956-09-3 | MFCD00864692 | 250MG
-- ₹ 47,419.20
Carvedilol
-- ₹ 10,900.78
Carvedilol
-- ₹ 62,471.08
Carvedilol
-- ₹ 22,126.30
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol
-- --
72956-09-3 | [3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine
-- ₹ 2,581.00 - ₹ 49,306.00

Related Products

Img

Sigma Aldrich

I0900000

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

L0050000

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

Y0001809

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

1012917

United States Pharmacopeia (USP) Re...

Img

Sigma Aldrich

N0080000

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

1511000

United States Pharmacopeia (USP) Re...

Img

Sigma Aldrich

M0220000

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

T1300000

European Pharmacopoeia (EP) Referen...

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Carvedilol EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
  • Biochem/physiol Actions: Cavedilol is a non-selective β-adrenergic blocker with α1 blocking activity. Carvedilol is used specifically for the treatment of heart failure and high blood pressure. It has been shown to improve left ventricular ejection fraction and may reduce mortality.
  • Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

Pictograms

GHS08,GHS09

Signal Word

Warning

Hazard Statements

H373,H411

Precautionary Statements

P260 - P273 - P314 - P391 - P501

Hazard Classifications

Aquatic Chronic 2 - STOT RE 2

Target Organs

Liver,spleen,Uterus (including cervix),Adrenal gland

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable